Zobrazeno 1 - 10
of 187
pro vyhledávání: '"single-inhaler triple therapy"'
Autor:
Vogelmeier CF, Beeh KM, Schultze M, Kossack N, Richter LM, Claussen J, Compton C, Noorduyn SG, Ismaila AS, Requena G
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 1835-1848 (2024)
Claus F Vogelmeier,1 Kai-Michael Beeh,2 Michael Schultze,3 Nils Kossack,4 Lena M Richter,4 Jing Claussen,5 Chris Compton,6 Stephen G Noorduyn,7,8 Afisi S Ismaila,8,9 Gema Requena10 1Department of Medicine, Pulmonary and Critical Care Medicine, Univer
Externí odkaz:
https://doaj.org/article/7bf00fe9cefe48c69896c215b1071c2d
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 97-110 (2024)
Michael Bogart,1 Lindsay GS Bengtson,2 Mary G Johnson,2 Scott H Bunner,2 Noelle N Gronroos,2 Kristi K DiRocco3 1US Value Evidence & Outcomes, R&D US, GSK, Research Triangle Park, NC, USA; 2Health Economics and Outcomes Research, Optum, Eden Prairie,
Externí odkaz:
https://doaj.org/article/6b75c671d245409e861dad6325781beb
Autor:
Czira A, Akiyama S, Ishii T, Wood RP, Camidge LJ, Wallis H, Jennison T, Wild RAC, Yarita M, Hashimoto K, Rothnie KJ, Ismaila AS
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 2933-2953 (2023)
Alexandrosz Czira,1 Shoko Akiyama,2 Takeo Ishii,2 Robert P Wood,3 Lucinda J Camidge,3 Hannah Wallis,3 Thomas Jennison,3 Rosie AC Wild,3 Masao Yarita,2 Kenichi Hashimoto,2 Kieran J Rothnie,1 Afisi S Ismaila4,5 1Value Evidence and Outcomes, R&D Global
Externí odkaz:
https://doaj.org/article/fe79fecb33c34628af72c0385405c12b
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 1815-1825 (2023)
Robyn Kendall,1 Alan A Martin,2 Dhvani Shah,3 Soham Shukla,4 Chris Compton,5 Afisi S Ismaila4,6 1ICON Health Economics, ICON plc, Vancouver, BC, Canada; 2Value Evidence and Outcomes, GSK, London, UK; 3ICON Health Economics, ICON plc, New York, NY, US
Externí odkaz:
https://doaj.org/article/7922c7f2936b44bfaa3c521b489ec07c
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 1575-1586 (2023)
Michael Bogart,1 Guillaume Germain,2 François Laliberté,2 Dominique Lejeune,2 Mei Sheng Duh3 1U.S. Value Evidence and Outcomes, R&D US, GSK, Research Triangle Park, NC, USA; 2Groupe d’analyse, Ltée, Montréal, QC, Canada; 3Analysis Group, Boston
Externí odkaz:
https://doaj.org/article/ebc2d56b898c40e8bf1ec9933c6381ad
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 407-418 (2023)
Nicola A Hanania,1 Scott H Bunner,2 Lindsay GS Bengtson,2 Afisi S Ismaila,3,4 Michael Bogart5 1Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA; 2Optum, Eden Prairie, MN, USA; 3Value Evidence and Outcomes,
Externí odkaz:
https://doaj.org/article/dda07446e3934f628d8997db14c3916f
Autor:
Giovanna Elisiana Carpagnano, Andrea Portacci, Silvano Dragonieri, Francesca Montagnolo, Ilaria Iorillo, Ernesto Lulaj, Leonardo Maselli, Enrico Buonamico, Vitaliano Nicola Quaranta
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 8, p 2320 (2024)
Background/Objectives: Several studies have demonstrated the positive clinical and functional impact of adding Long-Acting Muscarinic Antagonist (LAMA) to Inhaled Corticosteroids (ICS) and Long-Acting Beta-Agonists (LABA) therapy in the treatment of
Externí odkaz:
https://doaj.org/article/a1223a7f79fc4e8fa0db6cc8618a2094
Publikováno v:
Biomolecules, Vol 14, Iss 2, p 195 (2024)
Chronic obstructive pulmonary disease (COPD) is one of the major causes of disability and death. Maintenance use of inhaled bronchodilator(s) is the cornerstone of COPD pharmacological therapy, but inhaled corticosteroids (ICSs) are also commonly use
Externí odkaz:
https://doaj.org/article/7334d1d556d4498db9bf261aec4d9de9
Autor:
Paly VF, Vallejo-Aparicio LA, Martin A, Izquierdo JL, Riesco JA, Soler-Cataluña JJ, Abreu C, Biswas C, Ismaila AS
Publikováno v:
International Journal of COPD, Vol Volume 17, Pp 3097-3109 (2022)
Victoria Federico Paly,1 Laura Amanda Vallejo-Aparicio,2 Alan Martin,3 José Luis Izquierdo,4 Juan Antonio Riesco,5 Juan José Soler-Cataluña,6 Catarina Abreu,7 Chandroday Biswas,8 Afisi S Ismaila9,10 1ICON plc, Philadelphia, PA, USA; 2GSK, Madrid,
Externí odkaz:
https://doaj.org/article/d375b105155d48d5b3f76699c30178ec
Autor:
Gessner C, Trinkmann F, Bahari Javan S, Hövelmann R, Bogoevska V, Georges G, Nudo E, Criée CP
Publikováno v:
International Journal of COPD, Vol Volume 17, Pp 3019-3031 (2022)
Christian Gessner,1 Frederik Trinkmann,2,3 Sanaz Bahari Javan,4 Raimund Hövelmann,4 Valentina Bogoevska,4 George Georges,5 Elena Nudo,6 Carl-Peter Criée7 1Pneumologische Praxis Leipzig, Universitätsklinikum Leipzig, Institut für Klinische Immunol
Externí odkaz:
https://doaj.org/article/cfc52048361948df9ecf4986151bdb96